resveratrol has been researched along with corticosterone in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 23 (76.67) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andrisano, V; Barril, X; Bartolini, M; Carreiras, Mdo C; de los Ríos, C; García, AG; Huertas, O; León, R; López, B; López, MG; Luque, FJ; Marco-Contelles, J; Rodríguez-Franco, MI; Samadi, A; Villarroya, M | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Huang, M; Jiang, N; Kong, LY; Lan, JS; Wang, XB; Xie, SS | 1 |
| Kong, LY; Li, F; Li, XM; Wang, J; Wang, XB; Wang, ZM; Wu, JJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Guo, QL; Huang, SL; Huang, ZS; Li, D; Liu, ZQ; Ou, TM; Tan, JH; Wang, HG; Wang, N; Wu, JQ; Xia, CL | 1 |
| Cai, P; Kong, LY; Li, F; Liu, QH; Wang, J; Wang, XB; Wu, JJ; Yang, XL | 1 |
| Cai, P; Kong, LY; Li, F; Liu, QH; Wang, J; Wang, XB; Wu, JJ; Yang, HL; Yang, XL | 1 |
| Cai, P; Kong, LY; Li, F; Wang, J; Wang, XB; Wu, JJ; Yang, XL | 1 |
| Cai, P; Fang, SQ; Kong, LY; Liu, QH; Tang, YW; Wang, C; Wang, XB; Yang, HL; Yang, XL | 1 |
| Cai, P; Kong, LY; Liu, QH; Shi, CJ; Tang, YW; Wang, XB; Yang, HL; Yang, XL | 1 |
| Seidlova-Wuttke, D; Söder, O; Supornsilchai, V; Svechnikov, K; Wuttke, W | 1 |
| Belloni, AS; Malendowicz, LK; Nowak, M; Nussdorfer, GG; Ziolkowska, A | 1 |
| Gu, J; Jiang, H; Liu, D; Wang, J; Wang, X; Wang, Z; Xian, X; Xie, K; Zhang, Q | 1 |
| Chen, FH; Cheng, JQ; Ge, JF; Li, J; Pan, CX; Peng, L; Tang, J | 1 |
| Carrasco, C; Holguín-Arévalo, MS; Martín-Partido, G; Pariente, JA; Rodríguez, AB | 1 |
| Ge, L; Gu, J; Liu, D; Wang, X; Wang, Z; Xie, K; Yang, X | 1 |
| Baur, JA; Becker, LB; Guan, Y; Reilly, PM; Sims, CA; Wang, H; Widlund, AL | 1 |
| Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B | 1 |
| Girbovan, C; Kent, P; Merali, Z; Plamondon, H | 1 |
| Ali, SH; Bodduluru, LN; K V, A; Kasala, ER; Lahkar, M; Madhana, RM; Mahareddy, JR; Pitta, S | 1 |
| Chen, CF; Cheng, CY; Huang, YS; Li, IH; Ma, KH; Pao, LH; Shih, JH; Shiue, CY; Weng, SJ; Yeh, MK | 1 |
| Chen, JJ; Fang, XY; Li, YC; Liu, YM; Pei, YY; Shen, JD | 1 |
| Ahuja, S; Choudhary, S; Kumar, A; Mourya, A; Sah, SP | 1 |
| Chen, X; Geng, Z; Wang, L; Yang, L; Zhang, C; Zhao, X | 1 |
| Abd El-Fattah, AA; Ali, BM; Fahim, AT; Sadik, NAH | 1 |
| Arowolo, MA; Chen, F; He, J; He, S; Hu, R; Li, S; Yu, Q | 1 |
| Asghari, A; Baghaei Naeini, F; Hassanpour, S | 1 |
| Belyeva, LE; Buhler, AV; Fedotova, JO; Kamel, M; Karpenko, MN; Kovaleva, EG; Lazuko, SS; Maistrenko, VA; Novak, J; Tseilikman, OB; Tseilikman, VE | 1 |
30 other study(ies) available for resveratrol and corticosterone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Butyrylcholinesterase; Calcium; Calcium Channel Blockers; Catalytic Domain; Cell Death; Cell Line, Tumor; Cholinesterase Inhibitors; Cytosol; Dihydropyridines; Humans; Hydrogen Peroxide; Kinetics; Ligands; Models, Molecular; Peptide Fragments; Permeability; Tacrine | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Binding Sites; Blood-Brain Barrier; Cell Line, Tumor; Cell Survival; Chelating Agents; Coumarins; Drug Design; Humans; Metals; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Protein Structure, Tertiary; Rats | 2015 |
Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; Chelating Agents; Cholinesterase Inhibitors; Donepezil; Electrophorus; Horses; Humans; Indans; Indoles; Iron; Kinetics; Melatonin; Molecular Docking Simulation; Peptide Fragments; Piperidines; Protein Multimerization; Rats; Zinc | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Cell Death; Cell Line; Cholinesterase Inhibitors; Drug Design; Glutathione; Humans; Quinolines; Reactive Oxygen Species | 2017 |
Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Binding Sites; Blood-Brain Barrier; Chromones; Copper; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Protein Structure, Tertiary; Rats; Reactive Oxygen Species; Structure-Activity Relationship | 2017 |
Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Male; Mice; Mice, Inbred Strains; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; PC12 Cells; Protein Aggregates; Rats; Structure-Activity Relationship | 2017 |
Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Benzylamines; Blood-Retinal Barrier; Butyrylcholinesterase; Cell Death; Cholinergic Agents; Cholinesterase Inhibitors; Cinnamates; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Rats; Structure-Activity Relationship | 2017 |
Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Peroxide; Imines; Ligands; Lipopolysaccharides; Mice; Microglia; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Peptide Fragments; Protein Aggregates; Rats; Salicylates; Structure-Activity Relationship | 2017 |
Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Blood-Brain Barrier; Cell Line; Dimerization; Humans; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Oxidative Stress; Prenylation; Rats; Resveratrol; Structure-Activity Relationship | 2019 |
Phytoestrogen resveratrol suppresses steroidogenesis by rat adrenocortical cells by inhibiting cytochrome P450 c21-hydroxylase.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Bucladesine; Cells, Cultured; Corticosterone; Male; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Resveratrol; Steroid 21-Hydroxylase; Stilbenes | 2005 |
Endocrine disruptors and rat adrenocortical function: studies on freshly dispersed and cultured cells.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Benzhydryl Compounds; Benzophenones; Cell Count; Cell Culture Techniques; Cell Separation; Cells, Cultured; Corticosterone; Dose-Response Relationship, Drug; Endocrine Disruptors; Female; Phenols; Rats; Rats, Wistar; Resveratrol; Silymarin; Stilbenes; Time Factors; Zona Fasciculata; Zona Reticularis | 2006 |
Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognition Disorders; Corticosterone; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Male; Maze Learning; Neuroprotective Agents; Phosphorylation; Prefrontal Cortex; Rats; Recognition, Psychology; Resveratrol; Stilbenes; Stress, Psychological | 2014 |
Antidepressant-like effect of resveratrol: involvement of antioxidant effect and peripheral regulation on HPA axis.
Topics: Animals; Antidepressive Agents; Antioxidants; Base Sequence; Cell Line, Tumor; Corticosterone; DNA Primers; Humans; Hypothalamo-Hypophyseal System; Male; Malondialdehyde; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2013 |
Chemopreventive effects of resveratrol in a rat model of cerulein-induced acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Antioxidants; Ceruletide; Corticosterone; Female; Glutathione Peroxidase; Interleukin-10; Interleukin-1beta; Lipase; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Pancreas; Pancreatitis; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2014 |
Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats.
Topics: Animals; Antioxidants; Body Weight; Brain-Derived Neurotrophic Factor; Corticosterone; CREB-Binding Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Food Deprivation; Food Preferences; Gene Expression Regulation; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Stress, Psychological; Swimming; Time Factors | 2014 |
Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock.
Topics: Animals; Blood Glucose; Corticosterone; Glucagon; Glucagon-Like Peptide 1; Hypoglycemia; Insulin; Insulin Resistance; Kidney; Male; Mitochondria; Mitochondria, Liver; Rats, Long-Evans; Reactive Oxygen Species; Resuscitation; Resveratrol; Shock, Hemorrhagic; Stilbenes | 2014 |
Resveratrol Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice With Induced Adenomyosis.
Topics: Adenomyosis; Animals; Animals, Newborn; Behavior, Animal; Cluster Analysis; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glutamate Decarboxylase; Hyperalgesia; Mice, Inbred ICR; Myometrium; Nucleus Raphe Magnus; Pain Threshold; Phenotype; Reaction Time; Resveratrol; Stilbenes; Tamoxifen; Time Factors; Uterine Contraction; Uterus | 2015 |
Dose-related effects of chronic resveratrol administration on neurogenesis, angiogenesis, and corticosterone secretion are associated with improved spatial memory retention following global cerebral ischemia.
Topics: Adrenal Cortex; Animals; Behavior, Animal; Biomarkers; Brain Ischemia; CA1 Region, Hippocampal; Corticosterone; Dose-Response Relationship, Drug; Doublecortin Protein; Injections, Intraperitoneal; Male; Neovascularization, Physiologic; Neurogenesis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Random Allocation; Rats, Wistar; Reperfusion Injury; Resveratrol; Spatial Memory; Stilbenes | 2016 |
Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Gene Expression Regulation; Hippocampus; Male; Mice; Resveratrol; Stilbenes | 2015 |
Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
Topics: Animals; Benzylamines; Brain; Brain Mapping; Corticosterone; Depressive Disorder; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats, Sprague-Dawley; Resveratrol; RNA-Binding Proteins; Serotonin Agents; Stilbenes | 2016 |
Resveratrol Ameliorates the Depressive-Like Behaviors and Metabolic Abnormalities Induced by Chronic Corticosterone Injection.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Body Weight; Corticosterone; Depression; Disease Models, Animal; Drug Administration Schedule; Fluoxetine; Lipids; Male; Mice; Mice, Inbred ICR; Pioglitazone; Resveratrol; Stilbenes; Swimming; Thiazolidinediones | 2016 |
Plausible anti-inflammatory mechanism of resveratrol and caffeic acid against chronic stress-induced insulin resistance in mice.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Caffeic Acids; Corticosterone; Cytokines; Drug Therapy, Combination; Glyburide; Hypoglycemic Agents; Insulin Resistance; Male; Mice, Inbred Strains; Restraint, Physical; Resveratrol; Stilbenes; Stress, Psychological | 2016 |
Resveratrol beneficially affects meat quality of heat-stressed broilers which is associated with changes in muscle antioxidant status.
Topics: Animals; Antioxidants; Blood Glucose; Catalase; Chickens; Corticosterone; Diet; Dietary Supplements; Food Quality; Glutathione Peroxidase; Hot Temperature; Male; Malondialdehyde; Meat; Muscles; Resveratrol; Stilbenes; Stress, Physiological; Time Factors; Triglycerides | 2017 |
Resveratrol and dimethyl fumarate ameliorate depression-like behaviour in a rat model of chronic unpredictable mild stress.
Topics: Animals; Antidepressive Agents; Antioxidants; Apoptosis; beta Catenin; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Depressive Disorder; Dimethyl Fumarate; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Hippocampus; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Serotonin; Stress, Psychological | 2018 |
Effect of resveratrol on growth performance, rectal temperature and serum parameters of yellow-feather broilers under heat stress.
Topics: Adrenocorticotropic Hormone; Animals; Body Temperature; Chickens; Corticosterone; Diet; Dietary Supplements; Glutathione Peroxidase; Heat-Shock Response; Male; Oxidative Stress; Rectum; Resveratrol; Triiodothyronine; Weight Gain | 2019 |
Resveratrol exerts anxiolytic-like effects through anti-inflammatory and antioxidant activities in rats exposed to chronic social isolation.
Topics: Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antioxidants; Behavior, Animal; Corticosterone; Depression; Hippocampus; Rats; Resveratrol; Social Isolation; Stress, Psychological; Sucrose | 2023 |
Resistance to Resveratrol Treatment in Experimental PTSD Is Associated with Abnormalities in Hepatic Metabolism of Glucocorticoids.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenases; Animals; Corticosterone; Cytochrome P-450 CYP3A; Glucocorticoids; Humans; Hydroxysteroid Dehydrogenases; Rats; Resveratrol; Stress Disorders, Post-Traumatic | 2023 |